Firdapse and Ruzurgi both received orphan drug designations, which made Ruzurgi's approval complicated since it came after Firdapse. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
